Submitted by Anonymous (not verified) on 24 June 2025 - 15:55
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised